Diabetes has long been one of the most expensive medical conditions. In 2013 spending on care for people with the disease in the United States topped $100 billion. But it is also one of the most amenable to simple, low-cost behavioral interventions. At Geisinger, we set out to improve the health of diabetic adults by providing them with free, nutritious food and a comprehensive suite of medical, dietetic, social, and environmental services.
Thursday, November 30, 2017 from 6:15 p.m. to 8:30 p.m. at Inova Center for Personalized Health 3225 Gallows Road, Fairfax VA
The Inova Personalized Health Accelerator has made it our mission to increase the speed at which innovation enters the health system.
To celebrate this new venture we’re kicking off with a launch event to inspire, align, and connect our talented professionals, dedicated investor base and up-and-coming innovative startups in the area.
Incyte Corporation (NASDAQ:INCY) and MacroGenics, Inc. (NASDAQ:MGNX) announced today that the companies have entered into an exclusive global collaboration and license agreement for MacroGenics’ MGA012, an investigational monoclonal antibody that inhibits programmed cell death protein 1 (PD-1). Incyte has obtained exclusive worldwide rights for the development and commercialization of MGA012 in all indications, while MacroGenics retains the right to develop its pipeline assets in combination with MGA012.
After seeing the strength of the six finalist projects and evaluating each of the teams’ proposals, TEDCO board members decided to up their $300,000 offer, and fund every one of them.
LOCATION: Institute for Bioscience and Biotechnology Research (IBBR), 9600 Gudelsky Dr., Rockville, MD 20850
TIME: Thursday, November 30, 2017 – 3:00pm to 5:00pm
NIIMBL was formed to leverage a $70 million cost-shared agreement sponsored by the National Institute of Standards and Technology (NIST) into a $270 million public-private partnership to promote innovative technologies in bio-manufacturing in America. This information session will provide an overview of NIIMBL and explain how your organization can get involved!
Imagine walking into your doctor appointment and not only receiving a thoroughly researched diagnosis, but a menu of treatment options that match your condition, lifestyle and health goals.
Johns Hopkins Applied Physics Lab is set to begin construction on a new building that will be the Laurel-based facility’s largest.
Until recently, serial entrepreneur Naveen Jain’s most ambitious project was Moon Express, a literal moonshot that aims to land a rocket on our cratered neighbor and use its resources to make other planets livable for humans. His newest mission feels just as profound: create a world without chronic disease.
The University System of Maryland (USM) institutions have released a “Statement Supporting Open Access Dissemination of Scholarship,” a joint statement created by the university libraries of all 12 USM campuses. Councils representing the faculty, students, and the presidents of USM’s universities have collectively endorsed the statement. The statement explains the potential benefits to researchers who choose to make their works “freely available online either immediately upon completion, or within specified limited periods.”
Construction for the biomedical sciences building at the Universities at Shady Grove campus is on schedule, and county leaders are looking forward to landing state funds for new academic programs at the facility.
